Stonepine Capital Management, LLC Quant / Systematic

CIK: 0001440771 · Show all filings

Period: Q4 2016 (← Previous) (Next →)

Filing Date: Feb 10, 2017

Total Value ($000): $167,888 (89.7% shares, 10.3% debt)

Holdings (23)

— Recro Pharma, Inc. 13.8%

Value ($000) $23,167 Shares 2,874,317 Est. Cost $8.20 Unrealized —

— Aegerion Pharmaceuticals, Inc. 10.3%

Value ($000) $17,243 Shares 24,200,000 Est. Cost $0.60 Unrealized —

— Alere Inc. 8.4%

Value ($000) $14,029 Shares 360,000 Est. Cost $42.05 Unrealized —

— Sciclone Pharmaceuticals, Inc. 8.0%

Value ($000) $13,491 Shares 1,249,200 Est. Cost $10.80 Unrealized —

— Viveve Medical, Inc 7.9%

Value ($000) $13,297 Shares 2,599,711 Est. Cost $7.22 Unrealized —

— Novelion Therapeutics, Inc. 7.6%

Value ($000) $12,832 Shares 1,524,034 Est. Cost $8.42 Unrealized —

— Ophthotech Corp 6.6%

Value ($000) $11,075 Shares 2,292,900 Est. Cost $4.83 Unrealized —

— Cardiome Pharma Corp 5.2%

Value ($000) $8,718 Shares 3,158,816 Est. Cost $2.98 Unrealized —

ENTA Enanta Pharmaceuticals 4.6%

Value ($000) $7,769 Shares 231,913 Est. Cost $28.66 Unrealized 0.0%

VCYT Veracyte, Inc. 4.5%

Value ($000) $7,512 Shares 970,500 Est. Cost $7.48 Unrealized 0.0%

VCEL Vericel Corp 3.4%

Value ($000) $5,651 Shares 1,883,800 Est. Cost $2.52 Unrealized +1.9%

— Alimera Sciences, Inc 3.0%

Value ($000) $4,985 Shares 4,615,813 Est. Cost $1.25 Unrealized —

— Biodelivery Sciences INTL 2.7%

Value ($000) $4,551 Shares 2,600,711 Est. Cost $1.75 Unrealized —

— Sucampo Pharmaceuticals - CL A 2.3%

Value ($000) $3,848 Shares 284,002 Est. Cost $13.55 Unrealized —

CPIX Cumberland Pharmaceuticals, Inc. 2.0%

Value ($000) $3,407 Shares 619,538 Est. Cost $4.92 Unrealized +6.0%

— Flamel Technologies - SP ADR 2.0%

Value ($000) $3,388 Shares 326,087 Est. Cost $10.39 Unrealized —

— Trinity Biotech PLC - SPON ADR 1.8%

Value ($000) $3,018 Shares 436,066 Est. Cost $6.92 Unrealized —

— Durect Corporation 1.7%

Value ($000) $2,918 Shares 2,177,791 Est. Cost $1.37 Unrealized —

— Mallinckrodt PLC 1.3%

Value ($000) $2,174 Shares 43,629 Est. Cost $49.83 Unrealized —

— Cutera, Inc. 1.2%

Value ($000) $2,089 Shares 120,429 Est. Cost $11.59 Unrealized —

— Juniper Pharmaceuticals, Inc. 0.8%

Value ($000) $1,279 Shares 228,392 Est. Cost $5.56 Unrealized —

— CTI Biopharma Corp 0.6%

Value ($000) $1,067 Shares 2,617,136 Est. Cost $0.41 Unrealized —

— Aviragen Therapeutics, Inc. 0.2%

Value ($000) $380 Shares 309,278 Est. Cost $1.48 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Recro Pharma, Inc.	2,874,317	$23,167	13.8%	$8.20	—	COM	75629F109
—	Aegerion Pharmaceuticals, Inc.	24,200,000	$17,243	10.3%	$0.60	—	NOTE	00767EAB8
—	Alere Inc.	360,000	$14,029	8.4%	$42.05	—	COM	01449J105
—	Sciclone Pharmaceuticals, Inc.	1,249,200	$13,491	8.0%	$10.80	—	COM	80862K104
—	Viveve Medical, Inc	2,599,711	$13,297	7.9%	$7.22	—	COM	92852W204
—	Novelion Therapeutics, Inc.	1,524,034	$12,832	7.6%	$8.42	—	COM	67001K202
—	Ophthotech Corp	2,292,900	$11,075	6.6%	$4.83	—	COM	683745103
—	Cardiome Pharma Corp	3,158,816	$8,718	5.2%	$2.98	—	COM	14159U301
ENTA	Enanta Pharmaceuticals	231,913	$7,769	4.6%	$28.66	0.0%	COM	29251M106
VCYT	Veracyte, Inc.	970,500	$7,512	4.5%	$7.48	0.0%	COM	92337F107
VCEL	Vericel Corp	1,883,800	$5,651	3.4%	$2.52	+1.9%	COM	92346J108
—	Alimera Sciences, Inc	4,615,813	$4,985	3.0%	$1.25	—	COM	016259103
—	Biodelivery Sciences INTL	2,600,711	$4,551	2.7%	$1.75	—	COM	09060J106
—	Sucampo Pharmaceuticals - CL A	284,002	$3,848	2.3%	$13.55	—	COM	864909106
CPIX	Cumberland Pharmaceuticals, Inc.	619,538	$3,407	2.0%	$4.92	+6.0%	COM	230770109
—	Flamel Technologies - SP ADR	326,087	$3,388	2.0%	$10.39	—	SPONS ADR	338488109
—	Trinity Biotech PLC - SPON ADR	436,066	$3,018	1.8%	$6.92	—	SPONS ADR	896438306
—	Durect Corporation	2,177,791	$2,918	1.7%	$1.37	—	COM	266605104
—	Mallinckrodt PLC	43,629	$2,174	1.3%	$49.83	—	SHS	G5785G107
—	Cutera, Inc.	120,429	$2,089	1.2%	$11.59	—	COM	232109108
—	Juniper Pharmaceuticals, Inc.	228,392	$1,279	0.8%	$5.56	—	COM	48203L107
—	CTI Biopharma Corp	2,617,136	$1,067	0.6%	$0.41	—	COM	12648L106
—	Aviragen Therapeutics, Inc.	309,278	$380	0.2%	$1.48	—	COM	053761102